Approval · Notice of Compliance 29 · 2003
HEPSERA: Notice of Compliance 29
Issued August 27, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29
- Date
- August 27, 2003
- Company
- Gilead Sciences, Inc.Foster City, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HEPSERA | 02247823 | Cancelled Post Market |
Medicinal ingredients
- ADEFOVIR DIPIVOXIL 10 MG per TAB